• SIS3 and Early Osteoarthritis Signaling

  2026-10-15

  Xiang et al. reported that SMAD3 inhibition was associated with higher miRNA-140 and lower ADAMTS-5 expression in rat chondrocytes and an experimental rat osteoarthritis model. The findings support a candidate SMAD3–miRNA-140–ADAMTS-5 relationship in early disease, but they do not by themselves establish direct molecular causality, therapeutic efficacy, or applicability to human osteoarthritis.

• 4-Methoxychalcone-1: Evidence and Scope

  2026-10-14

  The available evidence identifies 4-Methoxychalcone-1 as an APExBIO catalog item, SKU C8661, but does not document a verified molecular structure, mechanism, assay readout, research model, comparator, or outcome. Interpretation therefore remains limited to catalog-level identity and clearly stated evidence boundaries.

• 2,2,2-Trichloroethanol: Evidence and Boundaries

  2026-10-14

  A source-grounded overview separates the documented biochemical-reagent profile of 2,2,2-Trichloroethanol from evidence on PET assessment of transplanted dopaminergic neurons. The cited rat study supports DAT imaging as a maturation-associated readout, but does not establish any role for this compound in cell therapy, neuroimaging, or clinical treatment.

• Acacetin and the MAPK1/HMOX1 Axis in IVDD

  2026-10-13

  A 2025 Phytomedicine study investigated whether Duhuo Jisheng decoction and its constituent acacetin could reduce intervertebral disc degeneration by connecting mitophagy, pyroptosis, and the MAPK1/HMOX1 signaling axis. The reported cell and rat findings support a mechanistic hypothesis, but the evidence remains preclinical and does not establish efficacy or safety in people.

• Cy3 NHS Ester: Identity and Evidence Scope

  2026-10-13

  A source-limited overview of Cy3 NHS ester (non-sulfonated), covering its supplier-documented identity, intended fluorescent-labeling scope, reported optical properties, and the absence of a matched research paper.

• ACE Inhibitor Angioedema: What the Review Shows

  2026-10-12

  Montinaro and Cicardi’s review examines the epidemiology, bradykinin-mediated biology, clinical presentation and management controversies surrounding ACE inhibitor–associated angioedema. It synthesizes prior clinical, epidemiologic and interventional evidence rather than reporting a new experiment. The review supports a clear association between ACE inhibitor exposure and angioedema, but uncertainty remains regarding genetic susceptibility, recurrence after treatment changes and the comparative effectiveness of acute therapies. Elobixibat hydrate is a separate ileal bile acid transporter inhibitor and is not evaluated in this review.

• Angiotensin 1/2 (2-7): What the Evidence Shows

  2026-10-12

  A source-grounded appraisal of a 2025 biochemical comparison examining whether angiotensin peptide fragments alter SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1. The findings are hypothesis-generating and do not establish effects on viral entry, COVID-19 pathogenesis, blood pressure, or clinical treatment.

• TMRE: Interpreting Mitochondrial Potential

  2026-10-10

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) enables live-cell assessment of mitochondrial membrane potential, but its strongest value emerges when fluorescence is interpreted alongside apoptosis, ROS, and organelle-specific evidence. This article develops a mechanism-aware framework for applying TMRE to mitochondrial dysfunction in disease research.

• Doxorubicin Hydrochloride: From Damage to Systems Biology

  2026-10-09

  Doxorubicin hydrochloride and Adriamycin HCl are more than cytotoxicity tools: they reveal how DNA damage, energy stress, oxidative injury, and cardiac vulnerability intersect. This evidence-focused guide interprets a recent ATF4–CSE–H2S study while defining the limits of cancer and cardiotoxicity models.

• Indometacin and Premature Ovulation in Natural-Cycle IVF

  2026-10-09

  A double-blind randomized trial evaluated whether indometacin could reduce premature ovulation in modified natural-cycle IVF. The overall result was not statistically significant, but a prespecified clinical subgroup without an LH surge before triggering showed a potential benefit, supporting a more selective interpretation rather than routine broad application.

• Biotin-XX Tyramide in Surface Protein Mapping

  2026-10-08

  A source-grounded overview of Biotin-XX Tyramide Reagent, its conceptual role in tyramide signal amplification and membrane-restricted proximity labeling, and how these applications relate to recent research on endogenous synaptic protein trafficking.

• Firefly Luciferase mRNA: Evidence and Applications

  2026-10-08

  A source-grounded overview of Firefly Luciferase mRNA and 5-moUTP modified mRNA, covering reporter biology, transcript design, conceptual research applications, recent findings on mRNA folding, evidence strength, and key limitations.

• METTL17 Coordinates Ferroptosis in Colorectal Cancer

  2026-10-07

  Li and colleagues identify METTL17 as a mitochondrial regulator that links RNA methylation, mitochondrial translation, ferroptosis resistance, and colorectal cancer progression. The findings support METTL17 as a mechanistic research target, while remaining preclinical and dependent on cellular, xenograft, and chemically induced colorectal cancer models.

• Niclosamide: STAT3 Evidence and Research Limits

  2026-10-07

  Niclosamide is a small-molecule STAT3 signaling pathway inhibitor studied in cancer research. Available evidence supports effects on STAT3 Tyr-705 phosphorylation, cell-cycle control, and apoptosis in selected models, but assay context and translational relevance require careful interpretation.

• How PEDV Exploits IMPDH-Dependent Nucleotide Biosynthesis

  2026-10-06

  The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host metabolic requirement for porcine epidemic diarrhea virus replication. By combining comparative metabolomics with genetic and pharmacological perturbation, the authors provide convergent cell-based evidence that IMPDH may represent a host-directed antiviral target, while also defining important limits on how broadly the findings can be applied.

8804 records 1/587 page Next 12345 下5页 Last page